F. Camacho

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

J. Chin, A. Zardan, A. Feifer, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

CUAJ – Original Research Gotto et al PROs in mCRPCP: Final results of COSMiC

A. Zardan, A. Feifer, V. Fradet, 2020 .